Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature
✍ Scribed by Søren L. Petersen; Aase Wagner; Peter Gimsing
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 177 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
Meningeal involvement of multiple myeloma is a very rare complication. Defining meningeal myelomatosis (MeM) as the presence of plasma cells in the cerebrospinal fluid in a patient with multiple myeloma, we have found 53 previously reported cases in the literature, where the diagnosis MeM has been made while the patient was alive. Using Kaplan Meier statistics we have found the median survival, from the time of diagnosis of MeM, to be 1.5 months. We report a case with MeM and possible cerebral myeloma shortly after autologous stem cell transplantation, and compare it with earlier published cases.
📜 SIMILAR VOLUMES
Background. Granular cell tumor was first described by Abrikossoff in 1926. It is rare and usually presents as a benign solitary lesion. Multifocal and malignant forms are known to occur. Methods. This presentation illustrates an additional case of granular cell tumor. Clinical and histological fea
## Abstract Allogeneic hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with myelodysplastic syndrome (MDS). Relapses after transplantation however, are not uncommon and are usually due to re‐emergence of a recipient derived, neoplastic, stem cell clone
## Abstract High‐dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard therapy for newly diagnosed multiple myeloma. Combinations of recently proposed prognostic factors such as cytogenetics and international scoring system (ISS) may be useful to predict prognosis